Delivery Order SPE2DB22D3016-SPE2DB24FANT5
Award Date 2/29/24
Potential Completion Date 3/1/24
Potential Value $17K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $22,448.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Ondansetron ODT 4 mg tablets to support military healthcare programs. It is a firm-fixed-price delivery order with an ultimate completion date of April 28, 2023. The contract was awarded through full and open competition, without any set-aside designation. Amerisourcebergen Drug Corp is a major...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $39,462.36, to provide Ondansetron ODT 4 mg Tablets. The contract has an ultimate completion date of November 7, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,621.75 firm-fixed-price delivery order is for Ondansetron ODT 4 mg tablets, with a completion date of January 11, 2024. Amerisourcebergen, which is a subsidiary of the parent company Cencora, Inc., holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award, valued at $6,409.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4563399049 - Ondansetron ODT 4 mg Tablet 30s, a prescription medication. The contract has an ultimate completion date of January 23, 2024 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is the prime contractor, and the contract was not set...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,121.87 firm fixed-price delivery order is for the supply of 4,567,317,333 units of the drug Ondansetron ODT 4 mg tablet. The contract has a period of performance through February 20, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $24,984.16 firm-fixed-price delivery order contract is for the supply of 4561411370 - Ondansetron ODT 4 mg Tablets, with a performance period through July 6, 2023. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $4,915.23, is for the delivery of Ondansetron ODT 4 mg tablets. The award has an ultimate completion date of May 10, 2024, and is structured as a firm fixed-price delivery order contract. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp is a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,752.72 firm fixed-price delivery order is for the supply of Ondansetron ODT 8 mg tablets. The contract has an ultimate completion date of May 6, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,191.50, is for the delivery of Ondansetron ODT 4 mg tablets. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of November 18, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds...
- This federal contract award valued at $1,041.90 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to deliver Ondansetron ODT 4 mg tablets. The contract is a delivery order under Cencora's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order...